Cyclosporine A in the Treatment of Juvenile Idiopathic Arthritis (JIA) Associated Chronic Anterior Uveitis

NCT00404482 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 60

Last updated 2009-06-03

No results posted yet for this study

Summary

Juvenile idiopathic arthritis (JIA) is often associated with chronic anterior uveitis. Presence of vision threatening complications may indicate immunosuppressive therapy. In this study, the experience with cyclosporine A (CsA) as mono- or combination-therapy is analyzed.

Conditions

  • Uveitis
  • Juvenile Idiopathic Arthritis

Interventions

DRUG

Cyclosporine A

Sponsors & Collaborators

  • St. Franziskus Hospital

    lead OTHER

Principal Investigators

  • Christoph Tappeiner, MD · Department of Ophthalmology at University Bern - Inselspital

Eligibility

Max Age
16 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
1991-01-31
Completion
2006-08-31

Countries

  • Germany

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00404482 on ClinicalTrials.gov